These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 958154)

  • 1. Carcinogenicity of drugs in small animals and mutagenicity in bacteria: what does it mean?
    Med Lett Drugs Ther; 1976 Aug; 18(18):74-6. PubMed ID: 958154
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of mutagenicity testing on pesticides.
    Shirasu Y
    Environ Qual Saf; 1975; 4():226-31. PubMed ID: 811466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of tests for carcinogenicity.
    Purchase IF
    IARC Sci Publ; 1980; (27):343-9. PubMed ID: 7002781
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risks of medical treatment. Part I: Monitoring for drug safety and efficacy.
    Schottenfeld D
    Clin Bull; 1980; 10(4):150-7. PubMed ID: 7011593
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance.
    Bercu JP; Hoffman WP; Lee C; Ness DK
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):270-7. PubMed ID: 18550240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic potential of drugs.
    Adamson RH; Sieber SM
    J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):377-85. PubMed ID: 6993614
    [No Abstract]   [Full Text] [Related]  

  • 9. 1,6-Dinitropyrene: mutagenicity in Salmonella and carcinogenicity in BALB/c mice.
    Tokiwa H; Otofuji T; Horikawa K; Kitamori S; Otsuka H; Manabe Y; Kinouchi T; Ohnishi Y
    J Natl Cancer Inst; 1984 Dec; 73(6):1359-63. PubMed ID: 6392672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative programme on long-term assays for carcinogenicity in Japan.
    Odashima S
    IARC Sci Publ; 1980; (27):315-22. PubMed ID: 7439964
    [No Abstract]   [Full Text] [Related]  

  • 13. [The necessity of determining the mutagenicity of new drugs].
    Bogajewski J; Schöneich J
    Pol Tyg Lek; 1982 Mar; 37(2):63-7. PubMed ID: 6750579
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for deployment of short-term assays for evidence of carcinogenicity.
    Drake JW; de Serres FJ; Darby WJ; Dunkel VC; Longfellow DG; Ott H; Purchase IF; Ramel C; Schlatter C; Smith EM
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):295-308. PubMed ID: 6935184
    [No Abstract]   [Full Text] [Related]  

  • 15. N-Substituted aryl compounds in carcinogenesis and mutagenesis.
    Weisburger EK
    Natl Cancer Inst Monogr; 1981 Dec; (58):1-7. PubMed ID: 7341965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative programme on short-term assays for carcinogenicity in Japan.
    Kawachi T; Yahagi T; Kada T; Tazima Y; Ishidate M; Sasaki M; Sugiyama T
    IARC Sci Publ; 1980; (27):323-30. PubMed ID: 6777298
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preclinical research--toxicology].
    Frohberg H
    Arzneimittelforschung; 1975 Jul; 25(7a):1101-10. PubMed ID: 1242337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research and development of new medicines.
    Ankier SI; Warrington SJ
    J Int Med Res; 1989; 17(5):407-16. PubMed ID: 2680676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the mutagenicity and carcinogenicity of hexachlorobutadiene].
    Chudin VA; Gafieva ZA; Koshurnikova NA; Nifatov AP; Revina VS
    Gig Sanit; 1985 May; (5):79-80. PubMed ID: 4040879
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.
    Kamber M; Flückiger-Isler S; Engelhardt G; Jaeckh R; Zeiger E
    Mutagenesis; 2009 Jul; 24(4):359-66. PubMed ID: 19447896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.